BeStock  
Stocks › Biotechnology › CRVS

Corvus Pharmaceuticals CRVS

US equityMarket cap rank #3290Biotechnology
$9.67 −$0.34 (-3.40%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.67 0.00%
Open$9.84
Prev close$10.01
Day range$9.56 – $10.04
Volume927.5K
Market cap$815.69M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts3
Average target$27.33+182.6% vs. price
  • Buy 100%
Low $27.00Now $9.67Avg $27.33High $28.00

Recent rating changes

The last 20 actions on file set price targets from $27.00 to $40.00, averaging $30.25.

DateFirmRatingTarget
11 Nov 2026 H.C. Wainwright BUY $27.00
6 Nov 2026 Barclays BUY $28.00
29 Oct 2026 Mizuho Securities BUY $27.00
11 Aug 2026 Mizuho Securities BUY $30.00
10 Aug 2026 H.C. Wainwright BUY $27.00
7 Aug 2026 Barclays BUY $28.00
7 Aug 2026 Oppenheimer BUY $33.00
1 Jul 2026 H.C. Wainwright BUY $27.00
12 Jun 2026 Mizuho Securities BUY $30.00
18 May 2026 Mizuho Securities BUY $30.00
15 May 2026 H.C. Wainwright BUY $27.00
15 May 2026 Barclays BUY $28.00
14 May 2026 Goldman Sachs BUY $40.00
11 May 2026 Mizuho Securities BUY $30.00
11 May 2026 Goldman Sachs BUY $40.00
8 May 2026 Barclays BUY $28.00
17 Apr 2026 Goldman Sachs BUY $40.00
16 Mar 2026 Mizuho Securities BUY $30.00
16 Mar 2026 Barclays BUY $28.00
13 Mar 2026 H.C. Wainwright BUY $27.00

Discussion

No comments yet — be the first to weigh in on CRVS.

Sign in to join the discussion.

Scroll to Top